Abstract
The objective of the study was to determine the association between intron 4 variable number of tandem repeats (VNTR), E298A and IVF 23+10 G/T polymorphisms of ec-NOS gene and sildenafil responsiveness in patients with erectile dysfunction (ED). Ninety-six patients who were evaluated for ED between November 2003 and June 2004 and 167 healthy individuals representing the normal population as controls were included in the present study. The patients were evaluated by medical history, five-item version of International Index of Erectile Function, serum glucose, testosterone levels and lipid profiles. Sixty-seven patients received four consecutive doses of sildenafil from 25 to 100 mg according to the response. The ec-NOS gene intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms were evaluated in the isolated DNA blood samples obtained from the patient group with ED (n=96), from the group received sildenafil (n=67) and from the healthy group (n=167). Genotype distributions of ec-NOS gene intron 4, E298A and IVF 23+10 G/T polymorphisms in the patient group were similar to those in the healthy group. The frequency of the ec-NOS gene intron 4 genotype were found as bb=41.7%, ab=50% and aa=8.3% in the sildenafil responders and bb=93.5% and ba=6.5% in the sildenafil non-responders. This finding was statistically significant. Statistical analysis of ec-NOS gene E298A and IVF 23+10 G/T polymorphisms did not reveal any significant difference between sildenafil responders and non-responders. These findings may indicate that ‘a’ allele of ec-NOS gene intron 4 VNTR polymorphism associates with a better sildenafil response.
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 8 print issues and online access
$259.00 per year
only $32.38 per issue
Buy this article
- Purchase on Springer Link
- Instant access to full article PDF
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Melman A, Gingell JC . The epidemiology and pathophysiology of erectile dysfunction. J Urol 1999; 161: 5–11.
Murray FT, Geisser M, Murphy TC . Evaluation and treatment of erectile dysfunction. Am J Med Sci 1995; 309: 99–109.
Ignarro LJ, Bush PA, Buga GM, Wood KS, Fukuto JM, Rajfer J . Nitric oxide and cyclic GMP formation upon electrical field stimulation cause relaxation of corpus cavernosum smooth muscle. Biochem Biophys Res Commun 1990; 31: 843–850.
Rajfer J, Aronson WJ, Bush PA, Dorey FJ, Ignarro LJ . Nitric oxide as a mediator of relaxation of the corpus cavernosum in response to nonadrenergic, noncholinergic neurotransmission. N Engl J Med 1992; 326: 90–94.
Burnett AL, Lowenstein CJ, Bredt DS, Chang TS, Snyder SH . Nitric oxide: a physiological mediator of penile erection. Science 1992; 257: 401–403.
Rajasekaran M, Mondal D, Agrawal K, Chen IL, Hellstrom W, Sikka S . Ex vivo expression of nitric oxide synthase isoforms (eNOS/iNOS) and calmodulin in human penile cavernosal cells. J Urol 1998; 160: 2210–2215.
Gruetter CA, Barry BK, McNamara DB, Gruetter DY, Kadowitz PJ, Ignarro L . Relaxation of bovine coronary artery and activation of coronary arterial guanylate cyclase by nitric oxide, nitroprusside and a carcinogenic nitrosamine. J Cyclic Nucleotide Res 1979; 5: 211–224.
Ignarro LJ . Introduction and overview. In: Ignarro LJ (ed). Nitric oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 1–19.
Goldstein I, Lue TF, Padma-Nathan H, Rosen RC, Steers WD, Wicker PA . Oral sildenafil in the treatment of erectile dysfunction. Sildenafil Study Group. N Engl J Med 1998; 338: 1397–1404.
Masters BS . Structural variations to accommodate functional themes of the isoforms of NO synthases. In: Ignarro LJ (ed). Nitric Oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 91–104.
Rosen RC, Cappelleri JC, Smith MD, Lipsky J, Pena BM . Development and evaluation of an abridged, 5-item version of the International Index of Erectile Function (IIEF-5) as a diagnostic tool for erectile dysfunction. Int J Impot Res 1999; 11: 319–326.
Eisenhardt A, Sperling H, Hauck E, Porst H, Stief C, Rubben C et al. ACE gene I/D and NOS 3 G 894T polymorphisms and response to sildenafil in men with erectile dysfunction. Urology 2003; 62: 152–157.
Miller SA, Dykes DD, Polesky HS . Simple salting out procedure for extracting DNA from human nucleated cells. Nucleic Acid Res 1998; 20: 1433–1440.
Yoon Y, Song J, Hong S, Kim J . Plasma nitric oxide concentrations and nitric oxide synthase gene polymorphisms in coronary artery disease. Clin Chem 2000; 46: 1626–1630.
Vernet D, Cai L, Garban H, Babbitt ML, Murray FT, Rajfer J et al. Reduction of penile nitric oxide synthase in diabetic BB/WORdp (type II) rats with erectile dysfunction. Endocrinology 1995; 136: 5709–5717.
De Meyer GRY, Herman AG . Nitric oxide and vascular endothelial dysfunction. In: Ignarro LJ (ed). Nitric oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 547–567.
Balligand JL, Feron O, Kelly RA . Role of nitric oxide in myocardial function. In: Ignarro LJ (ed). Nitric Oxide: Biology and Pathobiology. Academic Press: California, 2000, pp 585–607.
Wegner HE, Knispel HH, Klan R, Miller K . Efficacy of linsidomine chlorohydrate, a direct nitric oxide donor, in the treatment of human erectile dysfunction: results of a double-blind cross over trial. Int J Impot Res 1995; 7: 233–237.
Moody JA, Vernet D, Laidlaw S, Rajfer J, Gonzalez-Cadavid NF . Effects of long-term oral administration of L-arginine on the rat erectile response. J Urol 1997; 158: 942–947.
Acknowledgements
This study has been supported by a grant from Baskent University (KA: 04/26).
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Peskircioglu, L., Atac, F., Erdem, S. et al. The association between intron 4 VNTR, E298A and IVF 23+10 G/T polymorphisms of ecNOS gene and sildenafil responsiveness in patients with erectile dysfunction. Int J Impot Res 19, 149–153 (2007). https://doi.org/10.1038/sj.ijir.3901501
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1038/sj.ijir.3901501
Keywords
This article is cited by
-
CYP3A4 genotype is associated with sildenafil concentrations in patients with heart failure with preserved ejection fraction
The Pharmacogenomics Journal (2018)
-
An Updated Meta-Analysis of the Effects of the Endothelial Nitric Oxide synthase Gene G894T Polymorphism and Erectile Dysfunction Risk
Cell Biochemistry and Biophysics (2015)
-
Endothelial nitric oxide synthase genotypes and haplotypes modify the responses to sildenafil in patients with erectile dysfunction
The Pharmacogenomics Journal (2013)
-
eNOS and BDKRB2 genotypes affect the antihypertensive responses to enalapril
European Journal of Clinical Pharmacology (2013)
-
Association of coronary artery disease, erectile dysfunction, and endothelial nitric oxide synthase polymorphisms
Heart and Vessels (2009)